April 21 (Reuters) - Moderna said on Tuesday the European Commission had granted marketing authorization for a combination vaccine for the prevention of influenza and COVID-19 in adults 50 years of age and older.
Advertisement
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Shreya Biswas)
0 Comments